
Mochi Health Review
Best for: budget-conscious shoppers
Obesity medicine telehealth provider offering aggressively priced compounded GLP-1 programs.
What the monthly price covers
Medication
Billed separately
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Included
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Mochi Health is a solid telehealth option with balanced features and pricing.
Mochi Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $138/mo
- What's included
- Consult · Coaching
- Availability
- 15 states
- FDA status
- No FDA warning letter on record
How we scored Mochi Health
Each dimension is scored algorithmically from Mochi Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.8/10Mochi Health does not post a standard monthly cash price up front, so cost transparency is limited — confirm the ongoing rate before you commit.
Effectiveness25%
8.6/10Mochi Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.6/10Online intake and platform experience — consult included in the price; 3 platform features disclosed.
Trust & Safety15%
8.6/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-06-03).
Accessibility10%
7.0/10Mochi Health is available in 15 states — confirm yours is covered.
Support10%
7.7/10Coaching/dietitian access included.
How we verified this Mochi Health review
Last checked 2026-06-03- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in 15 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications Mochi Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check Mochi Health's current pricing and active discounts before you decide.
What we like
- Aggressively low monthly pricing
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Watch-outs
- Limited public information on program details
Mochi Health: a split-fee membership that can undercut almost everyone
Mochi Health is an obesity-medicine telehealth program built around one idea: keep the headline number low by separating the membership from the medication. Instead of charging a single all-in monthly price like most of its competitors, Mochi bills a flat monthly membership and then adds the cost of your compounded drug on top. For budget-conscious shoppers who do the math, the combined figure can land well below the category median of $169 a month — which is exactly why it earns its place on the value end of the rankings. But the two-part structure is also where most of the confusion lives, so it's worth understanding before you sign up.
How the two-part pricing actually works
Your bill has two stacked pieces. The first is a recurring membership fee that covers the clinical side — the prescriber, the dietitian, and the coaching. The second is a per-medication add-on that's charged separately: a lower add-on for semaglutide and a noticeably higher one for tirzepatide, reflecting the same drug-cost gap you'll see at every provider. You pick your membership term — one month, three months, or twelve months — and the longer commitments are how Mochi keeps the rate aggressive.
One honest caveat: Mochi's pricing has moved around. The membership fee has been quoted at different levels depending on whether a first-month promo is running, and the medication add-ons have shifted too. That means the all-in total you're comparing today may not be the all-in total you pay in month two. Treat any price you see — here or on the homepage — as a starting point and confirm the current membership rate, the promo terms, and the exact add-on for your drug at checkout before you commit.
What the medication side looks like
Mochi prescribes compounded GLP-1s only — there's no brand-name Ozempic, Wegovy, Mounjaro, or Zepbound here. You're choosing between compounded semaglutide and compounded tirzepatide, both delivered as injectables. Compounded medication is what makes the low pricing possible, but it also comes with the standard compounded-drug trade-offs: it's made by a compounding pharmacy rather than the original manufacturer, and the formulation and supply can vary with the regulatory environment. If having a brand-name pen matters to you, Mochi isn't the right fit.
What's bundled into the membership
The membership fee isn't just a gatekeeping charge — it buys real clinical access. Mochi includes unlimited contact with a physician and a registered dietitian, plus nutrition coaching sessions, as part of the standard plan. That dietitian-plus-coaching layer is genuinely useful and is something a lot of bargain-priced compounded programs strip out. Just note the medication itself is never included in the membership; it's always the separate add-on described above.
- Unlimited access to a physician and a registered dietitian
- Nutrition coaching sessions built into the membership
- Compounded semaglutide or tirzepatide, billed as a separate medication add-on
- Flexible terms — 1-month, 3-month, or 12-month subscriptions
The footprint problem: only 15 states
This is the single most important thing to check before you get excited about the price. Mochi Health is available in just 15 states — AZ, CO, FL, GA, IL, MA, MD, MN, NY, OR, PA, RI, TX, VA, and WA. If you don't live in one of those, the conversation ends there, no matter how attractive the membership math looks. That limited footprint is a real constraint, and it's a meaningful step down from the national providers that cover all 50 states.
Who should choose Mochi — and who should skip it
Mochi is a strong pick if you're price-driven, you live in one of its 15 states, you're comfortable with compounded medication, and you actually value having a dietitian and coaching in the loop rather than just a script. The longer-term membership in particular is where the value shows up.
Skip it if you want brand-name GLP-1s, if you live outside its service area, or if you need total cost certainty up front — the split membership-plus-add-on model and the history of price changes mean your monthly number takes a little homework to pin down. Shoppers who want one fixed all-in price with no moving parts will find simpler options elsewhere.
Trust, safety, and what we couldn't verify
On the reassuring side, there are no FDA warning letters on file for Mochi Health, and the included physician-and-dietitian model points to real clinical oversight rather than a pure prescription mill. The weaker spot is transparency: Mochi doesn't publicly name the compounding pharmacy behind its medication or publish accreditation details for it, and program specifics beyond the homepage are thin. We verify what's published, and a provider that doesn't disclose its pharmacy partner gets less confidence than one that does. You can see how we weigh these factors in our scoring methodology.
Bottom line
Mochi Health is a legitimately low-cost, dietitian-supported route to compounded semaglutide or tirzepatide — if you're in one of its 15 states and you're willing to manage a two-part bill that has a habit of shifting. The membership-plus-add-on structure rewards people who commit for the longer term and do their arithmetic. Just go in knowing two things cold: confirm the current all-in price for your specific drug before you pay, and accept that you're getting compounded medication from a pharmacy Mochi doesn't name. For value hunters who clear those hurdles, it's one of the cheaper credible options on the board.
Ready to start with Mochi Health?
Starting at $138/month. See current pricing and start your free consultation.
Alternatives to Mochi Health
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Mochi Health review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Mochi Health?
Starting at $138/month. See current pricing and start your free consultation.